Načítá se...
Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib
To improve the solubility and oral bioavailability of erlotinib, a poorly water-soluble anticancer drug, solid self-emulsifying drug delivery system (SEDDS) was developed using solid inert carriers such as dextran 40 and Aerosil® 200 (colloidal silica). The preliminary solubility of erlotinib in var...
Uloženo v:
| Vydáno v: | AAPS PharmSciTech |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984901/ https://ncbi.nlm.nih.gov/pubmed/26238806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-015-0370-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|